Treatment of age-related macular degeneration with aflibercept using a treat, extend and fixed protocol; A 4-year study of treatment outcomes, durability, safety and quality of life: An extension to the MATE randomised controlled trial

Archana Airody; Heidi Baseler; Julie Seymour; Victoria Allgar; Rajarshi Mukherjee; Louise Downey; Sushma Dhar-Munshi; Sajjad Mahmood; Konstantinos Balaskas; Theo Empeslidis; Rachel L. W. Hanson; Tracey Dorey; Tom Szczerbicki; Sobha Sivaprasad; Richard Peter Gale

doi:10.1111/aos.15774

Treatment of age-related macular degeneration with aflibercept using a treat, extend and fixed protocol; A 4-year study of treatment outcomes, durability, safety and quality of life: An extension to the MATE randomised controlled trial

Archana Airody^*, Heidi Baseler, Julie Seymour, Victoria Allgar, Rajarshi Mukherjee, Louise Downey, Sushma Dhar-Munshi, Sajjad Mahmood, Konstantinos Balaskas, Theo Empeslidis, Rachel L. W. Hanson, Tracey Dorey, Tom Szczerbicki, Sobha Sivaprasad, Richard Peter Gale

^*Corresponding author for this work

The Hull York Medical School

Research output: Contribution to journal › Article › peer-review

Original language	English
Number of pages	11
Journal	Acta ophthalmologica
Early online date	30 Sept 2023
DOIs	https://doi.org/10.1111/aos.15774
Publication status	E-pub ahead of print - 30 Sept 2023

Access to Document

10.1111/aos.15774

MEET THE RESEARCH TEAM EVENT: THE YORKSHIRE MACULAR DEGENERATION FUND
Heidi Baseler (Participant)
15 Nov 2024
Activity: Participating in or organising an event › Outreach (e.g. schools, community groups)

MATE: The MATE study: a 24 month, multicentre, pilot randomised controlled trial comparing standard care with individualised treat and extend regimen for treatment of neovascular age-related macular degeneraton with aflibercept.
Baseler, H. (Other), Gale, R. (Principal investigator) & Airody, A. (Student)
1/07/15 → 30/06/19
Project: Other project › Research collaboration

Cite this

Airody, A., Baseler, H., Seymour, J., Allgar, V., Mukherjee, R., Downey, L., Dhar-Munshi, S., Mahmood, S., Balaskas, K., Empeslidis, T., Hanson, R. L. W., Dorey, T., Szczerbicki, T., Sivaprasad, S., & Gale, R. P. (2023). Treatment of age-related macular degeneration with aflibercept using a treat, extend and fixed protocol; A 4-year study of treatment outcomes, durability, safety and quality of life: An extension to the MATE randomised controlled trial. Acta ophthalmologica. Advance online publication. https://doi.org/10.1111/aos.15774

@article{3703ce1547254b41ad9e5859cece3bc9,

title = "Treatment of age-related macular degeneration with aflibercept using a treat, extend and fixed protocol; A 4-year study of treatment outcomes, durability, safety and quality of life: An extension to the MATE randomised controlled trial",

author = "Archana Airody and Heidi Baseler and Julie Seymour and Victoria Allgar and Rajarshi Mukherjee and Louise Downey and Sushma Dhar-Munshi and Sajjad Mahmood and Konstantinos Balaskas and Theo Empeslidis and Hanson, {Rachel L. W.} and Tracey Dorey and Tom Szczerbicki and Sobha Sivaprasad and Gale, {Richard Peter}",

year = "2023",

month = sep,

day = "30",

doi = "10.1111/aos.15774",

language = "English",

journal = "Acta ophthalmologica",

issn = "1755-375X",

publisher = "Wiley-Blackwell",

}

Airody, A, Baseler, H, Seymour, J, Allgar, V, Mukherjee, R, Downey, L, Dhar-Munshi, S, Mahmood, S, Balaskas, K, Empeslidis, T, Hanson, RLW, Dorey, T, Szczerbicki, T, Sivaprasad, S & Gale, RP 2023, 'Treatment of age-related macular degeneration with aflibercept using a treat, extend and fixed protocol; A 4-year study of treatment outcomes, durability, safety and quality of life: An extension to the MATE randomised controlled trial', Acta ophthalmologica. https://doi.org/10.1111/aos.15774

Treatment of age-related macular degeneration with aflibercept using a treat, extend and fixed protocol; A 4-year study of treatment outcomes, durability, safety and quality of life: An extension to the MATE randomised controlled trial. / Airody, Archana; Baseler, Heidi; Seymour, Julie et al.
In: Acta ophthalmologica, 30.09.2023.

Research output: Contribution to journal › Article › peer-review

TY - JOUR

T1 - Treatment of age-related macular degeneration with aflibercept using a treat, extend and fixed protocol; A 4-year study of treatment outcomes, durability, safety and quality of life

T2 - An extension to the MATE randomised controlled trial

AU - Airody, Archana

AU - Baseler, Heidi

AU - Seymour, Julie

AU - Allgar, Victoria

AU - Mukherjee, Rajarshi

AU - Downey, Louise

AU - Dhar-Munshi, Sushma

AU - Mahmood, Sajjad

AU - Balaskas, Konstantinos

AU - Empeslidis, Theo

AU - Hanson, Rachel L. W.

AU - Dorey, Tracey

AU - Szczerbicki, Tom

AU - Sivaprasad, Sobha

AU - Gale, Richard Peter

PY - 2023/9/30

Y1 - 2023/9/30

U2 - 10.1111/aos.15774

DO - 10.1111/aos.15774

M3 - Article

SN - 1755-375X

JO - Acta ophthalmologica

JF - Acta ophthalmologica

ER -

Airody A, Baseler H, Seymour J, Allgar V, Mukherjee R, Downey L et al. Treatment of age-related macular degeneration with aflibercept using a treat, extend and fixed protocol; A 4-year study of treatment outcomes, durability, safety and quality of life: An extension to the MATE randomised controlled trial. Acta ophthalmologica. 2023 Sept 30. Epub 2023 Sept 30. doi: 10.1111/aos.15774

Treatment of age-related macular degeneration with aflibercept using a treat, extend and fixed protocol; A 4-year study of treatment outcomes, durability, safety and quality of life: An extension to the MATE randomised controlled trial

Access to Document

Activities

MEET THE RESEARCH TEAM EVENT: THE YORKSHIRE MACULAR DEGENERATION FUND

Projects

MATE: The MATE study: a 24 month, multicentre, pilot randomised controlled trial comparing standard care with individualised treat and extend regimen for treatment of neovascular age-related macular degeneraton with aflibercept.

Cite this